They could impair this rhythmic function by introducing mutated UNC-68, containing a specific causal RyR2 mutation in CPVT and furthermore alleviate this phenotype with a benzothiazepine compound. This evidence concerns the gene RYR2 and catecholaminergic polymorphic ventricular tachycardia.